Global High Potency API Contract Manufacturing Market Set to Double by 2032, Driven by Surge in Oncology Demand and Precision Medicine | FMI

The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, driven by a CAGR of 7% during the forecast period from 2022 to 2032, reflects the rising global demand for HPAPIs, particularly due …

High Potency API Contract Manufacturing Market Set to Reaching USD 16 Billion by 2032

The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, driven by a CAGR of 7% during the forecast period from 2022 to 2032, reflects the rising global demand for HPAPIs, particularly due …

High Potency API Contract Manufacturing Market Poised for a Robust 7% CAGR Growth by 2032-FMI Projection

The global high potency API contract manufacturing market size is predicted to grow at a 7% CAGR from 2022 to 2032, according to a recently released FMI analysis. At the conclusion of the assessment period, the market is anticipated to be valued at US$8 billion. Rising breakthroughs in high potency API (HPAPI) manufacturing technologies, combined …

Global High Potency API Contract Manufacturing Market | Key Takeaways and Future Projections

The Global High Potency API Contract Manufacturing Market Size was worth US$ 8 billion in 2022 and is predicted to be worth US$ 16 billion by 2032, growing at a CAGR of 7% during the forecast period. Because of the increasing frequency of cancer occurrences worldwide, the market is being driven by the use of …